Home Tags PBMs

Tag: PBMs

Nat Turner, 32, is the cofounder and CEO of Flatiron Health.

Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinica...

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.

Congress grilled little-known middlemen over the high cost of prescription drugs. Here’s how they defended themselves.

Pharmacy benefit managers are defending the tactics they use to keep prescription drug costs down and pointing the finger back at Big Pharma.
Pharmacy-benefit managers (PBMs), which are today increasingly owned by health insurers and pharmacy chains, will be facing tough questions about drug prices at a congressional hearing on April 9.

These powerful but little-known companies that have been blamed for high drug prices are now coming out of the shadows for a congressional interrogati...

The US has a high drug prices problem. These obscure but powerful companies will now face some tough questions on Capitol Hill.
Sanofi released this chart breaking down the French drugmaker's US sales last year as part of a congressional drug price hearing on Tuesday.

The CEO of a $210 billion pharma company says that US drug prices are working against patients. One chart explains why.

The CEO of the French drugmaker Sanofi provided an unusual look behind the curtain of US drug prices.
Chairman and CEO of Merck & Co., Kenneth Frazier, takes part in a panel discussion during the Clinton Global Initiative's annual meeting in New York, September 27, 2015.

The CEO of Merck has an ominous warning for the middlemen who stand between drug makers and patients

Merck CEO Kenneth Frazier thinks something has to change within the pharmaceutical industry to fix the issue of drug pricing. "I don't understand where we live in a world where 50% of the value goes to supply chain," Frazier said at an event at the Economic Club of New York.

CARL ICAHN: The $67 billion Cigna-Express Scripts merger may ‘rival the worst acquisitions in corporate history’

The billionaire investor Carl Icahn is not a fan of Cigna's plan to purchase the pharmacy benefit manager Express Scripts, a $67 billion deal that was announced in March. In a letter to Cigna stockholders sent Tuesday, Icahn said the deal "may well rival the worst acquisitions in corporate history."
Former Rockford Mayor Larry Morrissey

How a city in Illinois decided to sue to combat high drug prices after realizing it was spending $500,000 on one drug

A recent "60 Minutes" episode highlighted a lawsuit between Rockford Illinois, and a drugmaker over the rising cost of prescription drugs that led to the city spending half a million dollars treating two babies.

‘There’s other s— in the vial’: Bombshell lawsuit claims no one knows exactly what’s in a drug that’s cost the gov...

OPINION: The government has spent over a billion on a drug called Acthar and allegedly no one at the company even knows what it's actually made of.
Customers at a CVS store and pharmacy in Cambridge, Massachusetts, on December 4.

What CVS is doing to mom-and-pop pharmacies in the US will make your blood boil

Mom-and-pop pharmacies on the verge of going out of business blame CVS. They've rallied lawmakers — both Democrats and Republicans — to help.
NFL replacement Field Judge Shannon Eastin blows her whistle after throwing a penalty flag during the first half of the NFL football game between the Detroit Lions and St. Louis Rams in Detroit, Michigan September 9, 2012.

The biggest healthcare mergers of the year shouldn’t happen — period

OPINION: Neither CVS nor Express Scripts should get to make any moves before we know what's really going on inside the business of a pharmacy benefit manager.